Rare bleeding disorders Rare bleeding disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient has previously undergone a diagnostic WES analysis and provided written informed consent for unrestricted exome analysis and data sharing OR Patient has a severe bleeding tendency (ISTH-BAT >10) of unknown (genetic) origin and is part of a family with at least 3 family members with an elevated ISTH-BAT score (male >= 4, female >= 6). a. Participant is a family member (affected or unaffected) of an index patient
Exclusion criteria
Exclusion criteria: no informed consent provided Opt-out from incidental findings
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proven causality of a genetic variant for unexplained bleeding tendency of a patient. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To establish a causal relationship between genetic variants and bleeding phenotype - To improve the diagnostic yield for WES analysis in patients with unexplained bleeding tendency | — |
Countries
Netherlands
Contacts
Radboud Universitair Medisch Centrum